InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the detailed record of transactions filed by Olivier Soula, 首席执行官. Insider active across 1 company, notably ADOCIA. Cumulatively, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €150k. Activity tracked since 21 March 2024. The latest transaction was filed on 21 March 2024 (Acquisition). Regulator: AMF. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Olivier Soula is the Chief Executive Officer of ADOCIA, a company focused on developing innovative treatments for diabetes and other metabolic diseases. Under his leadership, ADOCIA is committed to improving patients' lives through advanced therapeutic solutions. Olivier Soula has extensive experience in the pharmaceutical and biopharmaceutical sectors, enabling him to guide the company towards new heights of innovation and growth.